Abstract
Three‐dimensional biofabrication using photo‐crosslinkable hydrogel bioscaffolds has the potential to revolutionize the need for transplants and implants in joints, with articular cartilage being an early target tissue. However, to successfully translate these approaches to clinical practice, several barriers must be overcome. In particular, the photo‐crosslinking process may impact on cell viability and DNA integrity, and consequently on chondrogenic differentiation. In this review, we primarily explore the specific sources of cellular cytotoxicity and genotoxicity inherent to the photo‐crosslinking reaction, the methods to analyze cell death, cell metabolism, and DNA damage within the bioscaffolds, and the possible strategies to overcome these detrimental effects.
Keywords: adult stem cells, arthritis, cytotoxic agents, tissue engineering, tissue regeneration
Three‐dimensional biofabrication using photo‐crosslinkable hydrogel bioscaffolds has the potential to revolutionize articular cartilage treatment. The photo‐crosslinking process may impact on cell viability and DNA integrity, and consequently on chondrogenic differentiation. In this review, we explore cellular cytotoxicity and genotoxicity inherent to the photo‐cross‐linking reaction, the methods to analyze them, and the possible strategies to overcome these detrimental effects.
Significance statement.
Several hurdles need to be addressed before the clinical translation of articular cartilage regeneration procedures using photo‐crosslinkable hydrogels. Cellular cytotoxicity and genotoxicity need to be identified and carefully detected to provide an indication of the safety of the repair treatment approach in patients.
1. INTRODUCTION
Biofabrication is the automated generation of biologically functional products with structural organization from living cells, bioactive molecules, biomaterials, and cell aggregates such as microtissues or hybrid cell‐material constructs.1 It has become an important tool within the regenerative medicine and the tissue engineering research field, providing new capabilities to create, for instance, implantable 3D constructs composed of biomaterials and living cells, intended as bioscaffolds. The biofabrication approach, of which the long‐term goal is to switch from nonbiological prosthesis to biological implants has generated promising results in the repair of articular cartilage.2 Traumatic cartilage (chondral) injuries can result in osteoarthritis, a major source of disability in the developed world.3 Current treatments to repair chondral lesions, which include autologous chondrocyte implantation, mosaicplasty, and microfracture, are unable to reproduce hyaline cartilage capable of sustaining shear and compressive forces associated with normal joint function. The generation of a bioscaffold, using a combination of biomaterials and cells, is a possible solution for cartilage repair.4 Currently, this technology has generated promising results both in vitro5 and in in vivo6 as well as in preclinical studies.7 Nevertheless, there are several open questions with respect to its clinical use,8 especially regarding the safety of the cells implanted, given the multiple sources of cytotoxicity and genotoxicity intrinsic to the bioscaffold generation process. In particular, the chemistries required to generate covalently crosslinked 3D hydrogel environments can have cytotoxic impacts on embedded cells. To our knowledge, the wider literature describing these issues has not previously been critically examined. Thus, the aim of this review is to summarize the sources of cellular damage and provide an indication on the reliable tests to be used to verify the safety of the cells implanted in bioscaffolds. Limitations of current surgical treatments for cartilage repair such as microfracture have prompted the field of cartilage regenerative medicine to integrate engineering and biological principles to promote the growth of new cartilage to replace the damaged tissue. To date, a wide range of scaffolds and cell sources have emerged toward cartilage tissue engineering, with a focus on recapitulating microenvironments present during the human body development or in the adult tissue. These microenvironments should induce the formation of cartilaginous constructs with biochemical and mechanical properties similar to the native tissue. Hydrogels have emerged as a promising scaffold material due to the wide range of properties that are possible to achieve, and the ability to trap cells within the material.9
2. PHOTO‐CROSSLINKABLE HYDROGEL BIOSCAFFOLDS FOR ARTICULAR CARTILAGE REPAIR: GENERAL OVERVIEW
Cartilage biofabrication strategies are designed to overcome the limitations of injection‐based stem cell therapies; namely, the massive cell death upon delivery caused by shear stress from the needle, poor engraftment of delivered cells and, as a consequence, limited ability to differentiate into a chondrogenic phenotype.10, 11 Rather than injecting cells directly, one alternative is to deliver stem cell laden hydrogel bioscaffolds to fill the defect. The encapsulating hydrogel has a protective effect on the cells from shear stress and mechanical cytotoxicity coming from the extrusion or the bioprinting process. The 3D microenvironment provided by the hydrogel scaffold supports cell survival and can stimulate differentiation into mature chondrocytes capable of producing their own extracellular matrix. The scaffold is typically designed to degrade over time while it is replaced by newly formed cartilage tissue arising from the cells implanted, producing a tissue which resembles the native articular cartilage. Traditional techniques to generate bioscaffolds include casting of cell‐laden hydrogel‐based materials in molds of the desired size and structure to be implanted in the defects to be treated, but also inkjet 3D bioprinting, micro‐extrusion, in situ bioprinting (Table 2). More advanced biofabrication techniques include the production of neocartilage tissue to better recapitulate the native zonal architecture of the articular cartilage, or the generation of multiphasic constructs with hybrid approaches using different materials, 3D printing techniques,12 or different cell sources and lineages.13
To achieve encapsulation, the cells are typically mixed with a liquid hydrogel solution, which is then crosslinked to form a contiguous stable network under physiological conditions.
Since the behavior of chondrocytes is, in part, mediated by the mechanical environment, matching the mechanical properties of the scaffold to that native cartilage also needs to be considered.14 However, the crosslinking reaction can impact on cell viability and metabolism, and consequently on chondrogenic differentiation. One of the most widely adopted crosslinking strategy uses polymers (naturally derived or synthetic) which have been modified with reactive groups (methacrylate and/or methacrylamide) which can undergo chain polymerization reactions.15, 16, 17 The process of protein crosslinking comprises among all chemical, enzymatic, chemo‐enzymatic, self‐assembly, ionic, thermal formation of new covalent bonds between polypeptides.18 These reactions allow the site‐directed coupling of proteins with distinct properties and the de novo assembly of polymeric protein networks. The chemical photo‐crosslinking process is the most investigated and the most common way to achieve a precise spatial and temporal hardening of the hydrogels. At the same time, it is the one that deserves much attention given the presence of different drawbacks that can impair cell viability. One of the main advantages of photo‐crosslinking is the rapid formation of hydrogel networks at ambient temperature under mild conditions, and the tunability of the mechanical properties. The crosslinked site is also ready to be accurately selected, because the photoinitiated polymerization takes place under light exposure and only the irradiated areas are involved in hydrogel crosslinking. The ionic/electrostatic interactions can instead achieve extremely limited mechanical strength. Moreover, the photo‐crosslinking process is the preferable choice to perform in situ bioprinting with robotic arms or handheld approaches,19 which is emerging as a favored bioprinting strategy during certain clinical situations when compared with conventional in vitro bioprinting. Finally, the photo‐crosslinking strategy allows to a precise temporal and spatial control compatible with the time frame in theater for surgical operations.
In the light‐induced crosslinking process, a photoinitiator (PI) molecule is mixed within the reactive hydrogel, and the reaction is initiated through exposure to UV or visible light of a wavelength (Figure 1). However, such photo‐crosslinking reactions can create a transiently cytotoxic environment, which may compromise cell viability and/or phenotype.20 Other sources of cytotoxicity inherent in the bioscaffold generation process include the shear stresses during the extrusion and the poor diffusion of nutrients or oxygen through the crosslinked hydrogels.21
Extended “fabrication times” involving exposure to nonphysiological conditions, such as room temperature or the lack of control of oxygen and CO2 levels within an enclosed bioprinting cartridge, can also have a strong impact on viability in later culture.22, 23
The clinical application of articular cartilage repair strategies will require the identification, quantification, and mitigation of such toxic effects. The scope of this review is to cover the specific sources and detection methods of cellular cytotoxicity and genotoxicity inherent to the photo‐crosslinking reaction.
Thus, in the following sections, we will examine: (a) the sources and effects of the photo‐crosslinking process on cells viability and DNA integrity; (b) the methods to analyze cell death, metabolism and DNA damage within the bioscaffold; and (c) potential solutions to overcome these detrimental effects.
3. PHOTO‐CROSSLINKABLE HYDROGEL BIOSCAFFOLDS FOR ARTICULAR CARTILAGE REPAIR: COMPONENTS AND PROCEDURES
The assessment of the cytotoxic and genotoxic effects of the photo‐crosslinking process requires preliminary consideration of the type of hydrogels and cells that constitute the bio‐ink and therefore the final bioscaffold. Although the type of cells may differ in their susceptibility to cyto‐ and genotoxic effects, the hydrogel itself can influence cell survival and behavior through the presence of functional groups and bioactive moieties that favor its hardening. Finally, the method of delivering the bioscaffold may influence the crosslinking conditions.
3.1. Sources of cells
Adult mesenchymal stem cells possess self‐renewing abilities and inherent chondrogenic properties which lend to be the elective cell type in cartilage regeneration.24 In particular, human adipose‐derived stem cells (hADSCs) have been incorporated into many different scaffold‐based systems and have shown promising results in cartilage tissue engineering.25 The two major sources of hADSCs are abdominal fat and infrapatellar fat pad (IFP).26 The IFP can be opportunistically harvested during routine surgical procedures such as knee arthroplasty or arthroscopy, and is known to have high chondrogenic potential.27 Bone marrow‐derived stem cells share common properties with hADSCs but are limited due to low tissue availability and cell number, and inferior chondrogenic potential compared with IFP‐derived stem cells.28 Mature chondrocytes instead possess poor replicative capacity and are prone to dedifferentiation, thus are not ideal for the purpose of cartilage regeneration.29 hADSCs are currently under consideration for several clinical applications (https://www.clinicaltrial.gov/),24, 30 and they are known to accumulate DNA damage and undergo senescence during in vitro cultivation, so stem cell preparations already undergo rigorous testing in order to ensure safety for the recipient.31 These cells are also known for their resistance to chemotherapeutics drugs and their promising use as drug delivery tools, especially for bone‐derived tumors.32, 33, 34 Another source of chondrogenic cells for articular cartilage repair are nasal chondrocytes. In fact, hyaline‐like cartilage tissues, engineered from autologous nasal chondrocytes, have shown promising results in a human clinical trial in patients with traumatic full thickness cartilage lesions.35
3.2. Photo‐crosslinkable hydrogels and crosslinking process
The ideal hydrogel for cartilage regeneration is one that resembles the natural extracellular matrix of cells to support cell survival and differentiation and thus to form functional articular tissue.36 Natural hydrogels such as gelatin display high biocompatibility and biodegradability.37 Gelatin is composed of hydrolyzed collagen and retains abundant Arginine‐Glycine‐Aspartate sequence motifs which serve as cell attachment sites, and it contains matrix metalloproteinase sensitive degradation sites. These bioactive motifs facilitate cell adhesion, proliferation, and differentiation via integrin‐mediated cell adhesion and cell‐mediated enzymatic degradation. However, in order to be used as a biomaterial, gelatin needs to be modified to gain irreversible crosslinking, necessary strength, and precise mechanical tunability.38 This problem can be overcome by the addition of functional groups such as methacrylate/methacrylamide, which can be crosslinked after the activation of a PI, to form gelatin methacryloyl (GelMa) (Figure 2). This achieves mechanical tunability while retaining the biocompatibility of gelatin, making GelMa the most popular choice of hydrogel in hydrogel‐based cartilage repair.
Similarly, hyaluronic acid, which supports cell differentiation along the chondrogenic lineage, can be modified to form cross‐linkable methacrylated hyaluronic acid (HAMa) which, when combined with GelMa to form GelMa‐HAMa, increases the mechanical properties of tissue engineered articular cartilage.40, 41 Nevertheless, GelMA itself does not contain all the required biofunctionality to support chondrogenic differentiation of the stem cells. As such, HAMa is acting also as one of the biological molecules to enhance the chondrogenic potential of a bioscaffold, together with other additives such as methacrylated chondroitin sulfate (CS‐Ma), or even combination of both HaMA and CS‐Ma in GelMA.42
Synthetic hydrogels such as polyethylene glycol (PEG) exhibit limited biocompatibility compared with natural hydrogels but are useful for their superior mechanical properties.43 Introduction of acrylate functional groups forming polymerizable PEG diacrylate (PEGDA) as well as the addition of other moieties to improve the biological properties has propelled PEGDA to become a popular hydrogel choice in cartilage tissue engineering.44, 45, 46
Hydrogel crosslinking can be achieved via a photoinitiated but also enzymatic system. Enzymatic crosslinking commonly utilizes transglutaminases, tyrosinases, or peroxidases to catalyze the formation of highly resistant covalent bonds between polymer chains.47 The main drawbacks are the instability of some of the enzyme types, especially transglutaminases and tyrosinases, and the limited mechanical properties of the gels formed. As described above, photo‐crosslinking has been demonstrated to provide excellent temporal and spatial control over the process hence allows greater control of the mechanical properties of the resultant matrix compared with the indirect enzymatic process.48 The reaction involves the usage of light of a specific wavelength to strike the PI, which in turn is cleaved into two free radicals (Figure 3). One or both of these free radicals then radicalize a nearby reactive functional group (methacrylate or methacrylate) which propagates the polymerization chain reaction.
As the reaction proceeds the number of the crosslinks in the system increases exponentially resulting in a biopolymer network linked through polymethacryloyl chains.43 The degree of crosslinking and therefore the degree of mechanical stiffness is a result of PI type and concentration, light intensity, wavelength, exposure time, and degree of methacrylation.50 Although the photo‐crosslinking process is efficient and is somewhat controllable, it presents three major potential sources of cellular toxicity: generation of free radicals, exposure to the PI molecule itself, and exposure to light. Ultimately, the toxicity introduced by the photo‐crosslinking process must be minimized to achieve a crosslinked hydrogel with optimal mechanical stiffness, maximal cell viability, and minimal DNA damage.
4. SOURCES OF CYTOTOXICITY AND GENOTOXICITY
4.1. Light source and irradiation
The photo‐crosslinking process commonly employs an ultraviolet (UV) light source which is by itself a potential source of cytotoxicity, due to UV induced apoptosis and most importantly, genotoxicity when DNA damaged cells are not eliminated. Long‐wave UV (A, 315‐400 nm) is widely accepted as a mutagen owing to its ability to induce cellular DNA damage, and shortwave UV (B, 280‐315 nm) irradiation can lead to DNA base lesions such as cyclobutane pyrimidine dimers (CPDs), and pyrimidine 6‐4 pyrimidone photo‐products.51 Higher wavelength UV‐A (315‐400 nm) induced cytotoxicity occurs mostly via indirect mechanisms, whereby cellular chromophores act as photo‐sensitizers to generate reactive oxygen species (ROS) which causes insult to proteins, lipids and DNA, the main lesion being the oxidized base 8‐oxo‐7,8‐dihydroguanine (8‐oxoG).52, 53 Similarly to CPDs, 8‐oxoG can pair with adenine and cause a guanine:cytosine to thymine:adenine transversion, but can also result in DSBs if inserted during DNA replication.54 Other studies identified an action spectra to determine cell killing and mutations by monochromatic ultraviolet and visible radiations (254‐434 nm) in human epithelial cells.55
More recently, the cytotoxicity of UV‐A1 radiation was tested in human mesenchymal stem cells and data show that a prolonged 2‐hour exposure to high intensity (370 ± 5 nm; 788 kJ/m2) in the absence of any PI, results in a significant reduction of cell viability of up to 50% compared with cells exposed to visible light only.56 Nevertheless, it has also been demonstrated that low‐dose and long‐wave UV‐A light do not affect their gene expression, making ideal cells candidate for their low susceptibility to cytotoxic and genotoxic effects derived from a photo‐crosslinking reaction.57
Double‐stranded breaks (DSBs), which are considered the most deleterious type of DNA damage, can be caused as a direct result of these lesions and indirectly through the production ROS.58 Inbuilt cellular mechanisms to avoid mutagenesis include DNA repair, apoptosis or cell cycle arrest. However, should these mechanisms fail, these genomic lesions can result in tumor formation59, 60 (Figure 4).
4.2. Photoinitiator molecules
The optimal PI is one that generates phase transformation of hydrogels from gel to solid to withstand required compressive forces for the target tissue while remaining minimally toxic to the encapsulated cells. The PI itself has intrinsic toxic effects although this varies between PIs and can be minimized by selecting the lowest practicable concentration; although reducing the PI concentration necessitates an increase to the light exposure time or intensity, it needs to achieve equivalent mechanical properties.50 The toxicity of PI molecule relates to its chemical structure, especially its hydrophobicity, which increases its potential to cross the cellular membrane. A comparative study between three PIs, Irgacure 2959 (2‐hydroxy‐4′‐(2‐hydroxyethoxy)‐2‐methylpropiophenone), Irgacure 184 (1‐hydroxy‐cyclohexyl‐phenyl‐ketone), and Irgacure 651 (2,2‐dimethoxy‐1,2‐diphenylethan‐1‐one), found that Irgacure 651, the most nonpolar molecule of the PIs, exhibited the highest cytotoxicity whereas Irgacure 2959, which has a relatively polar structure, was the least toxic.61 Several studies have analyzed the individual effects of the different components of the photo‐crosslinking process on cell viability in 2D by exposing cells to UV irradiation, PI alone, and PI with UV irradiation.20, 61, 62 Table 1 summarizes the intrinsic toxicity of different PI molecules. However, to be comparable, the susceptibility of the cell type used, the concentration of the PIs, the exposure times to light and the techniques used to generate the bioscaffolds must be carefully taken into consideration, but this was beyond the principal scope of the review. Furthermore, as PIs vary in their crosslinking efficiency, the concentration required for hydrogel hardening differs between PI types. For this reason, toxicity and efficiency should both be considered in choosing the ideal PI. As an example of intrinsic toxicity, the LAP (lithium phenyl‐2,4,6‐trimethylbenzoylphosphinate) PI molecule has been studied in relation to cellular survival: in a 2D culture of hADSCs, the survival of cells was highly affected by exposure to UV light at 365 nm, with an irradiance of 700 mW/cm2 for 10 seconds in combination with LAP, as well as to LAP alone, but not to UV light itself (Figure 5). This was one of the main aspects that prompted the exploration of protective elements for the cells, such as, for example, their encapsulation in hydrogel or a spatial separation from the PI (ie, coaxial printing techniques that can separate cells from direct contact with the PI). These strategies have been demonstrated to significantly reduce the cytotoxic effect of these chemicals.
Table 1.
PI | Peak absorbance wavelength | Toxicity | References |
---|---|---|---|
Irgacure 2959 | 365 nm UV‐A | Between 0.05% and 0.1% viability of hBMSCs and bovine chondrocytes ≈90% | 20, 61, 63 |
VA086 | 370‐405 nm UV‐A | Up to 1.4%, bovine chondrocyte viability >90% | 63 |
Camphorquinone | 400‐520 nm VIS | hGF treated with 0.5‐2.5 mM CQ had similar viability to untreated cells | 64 |
LAP | 365‐490 nm VIS | At 0.1% hADSCs demonstrated a significant reduction in viability | 62 |
Eosin Y‐TEA | 470‐550 nm VIS | 0.1 mM EY and 1.5%v/v TEA are “very toxic” to hMSCs | 65 |
Rose Bengal (RB) | VIS | At 0.01%, rBMSCs viability is ≈80%, but at 0.1% this falls to ≈30% | 66 |
Abbreviations: Camphorquinone, 2,3‐bornanedione; hADSC, human adipose‐derived stem cells; hBMSC, human bone marrow‐derived stem cells; hGF, human gingival fibroblasts; hMSCs, human mesenchymal stem cells; Irgacure 2959, 2‐hydroxy‐4′‐(2‐hydroxyethoxy)‐2‐methylpropiophenone; LAP, lithium phenyl‐2,4,6‐trimethylbenzoylphosphinate; rBMSC, rabbit bone marrow‐derived stem cells; Rose Bengal, 4,5,6,7‐tetrachloro‐2′,4′,5′,7′‐tetraiodofluorescein; TEA, triethylamine; VA‐086, 2,2′‐azobis[2‐methyl‐N‐(2‐hydroxyethyl)propionamide].
4.3. Free radicals
As discussed above, photoinduced free radicals are highly reactive species, chosen for their ability to trigger a radical polymerization reaction. However, they can also interact with double bonds within cellular components such as membranes, proteins, and DNA, thus threaten cell viability, metabolism, and DNA integrity.
The toxicity of free radical can arise through direct effects, as well as indirect effects, such as the formation of ROS upon reaction of a free radical with the environmental oxygen.67 Oxidative degradation of lipids which constitute the cell and mitochondrial membranes produce toxic aldehyde end products such as 4‐hydroxynonenal (4‐HNE). 4‐HNE is particularly cytotoxic and mediates this effect through depletion of glutathione, a potent antioxidant that has a role in mitochondrial redox reactions, and the formation of mitochondrial protein adducts.68 The subsequent disruption of mitochondrial function activates intrinsic apoptotic pathways, although it should be noted that at very high concentrations, acute cell death by necrosis can occur.69 In terms of genotoxicity, free radical‐induced DNA damage can take the form of base lesions, damage to the sugar moiety, tandem lesions, DNA‐protein crosslinks, single, and double strand breaks.70 Of the bases, guanine is most susceptible to oxidative stress leading most commonly to the formation of 8‐oxoG lesions as discussed above, but also to other products such as imidazolone and spirodihydantoin.71 These different oxidative lesions will result in different transversion mutations unless adequate DNA base excision repair mechanisms are used. If resulting mutations occur within critical regions of the genome responsible for regulating cell proliferation such as tumor suppressor genes or oncogenes, dreaded malignant transformation of cells the can arise.72 DSBs can be repaired by nonhomologous end joining, an error prone mechanism that often introduces mutations.73 Direct induction of DSBs occurs through a reaction between hydroxyl radicals and the DNA molecule producing single strand breaks. When two closely opposed single strand breaks, commonly referred to as “clustered damages,” form, the molecule cannot be resealed thus converts into a DSBs.74 In addition to breaks, repair of other clustered DNA lesions by simultaneous base excision repair can result in single strand breaks which can convert to DSBs.75 Finally, during DNA replication, the presence of single strand breaks or other DNA lesions such as interstrand crosslinks or DNA‐protein crosslinks can hinder the normal replicative process leading to a collapse of the replication fork and DSBs formation.76 As such, the formation of less harmful lesions such as base lesions described in the paragraph above have the potential to form these highly risky DSBs.
The reduction in cell viability due to cytotoxic effects of free radical photoinitiation has been well characterized across different PI types. Fedorovich et al demonstrated that the combination of UV light with Irgacure 2959 resulted in the highest cytotoxicity compared with the two modalities alone.20 Similar results were generated with LAP and RB indicating that the PI toxicity is drastically exacerbated by photoactivation.62, 65, 66
More concerning than cell death is the damage to cells that survive despite free radical induced toxicity. Evidently, the significant drop in cell metabolic activity immediately after high intensity UV crosslinking, and the progressive decline over the following week, suggests that engendered free radicals from light‐induced PI degradation causes irreparable damage to cellular processes.50 O'Connell et al demonstrated in fact that although metabolic activity declined, cell survival remained high (>90%) which raises concern that damaged cells could contain DNA‐base lesions. As discussed earlier, depending on the genes where these lesions occur, tumor formation within the generated bioscaffold could result, rendering this technology unsafe for clinical application.
5. TECHNIQUES FOR ANALYSIS OF CYTOTOXICITY AND GENOTOXICITY
The rate of survival and safety of cells in the bioscaffolds need to be carefully evaluated through an assay that can detect markers of live, dead, and damaged cells, and that can penetrate the crosslinked hydrogel. The conventionally used assay LIVE/DEAD viability kit (e.g., Thermo Fisher Scientific Inc., Waltham,MA, USA, https://www.thermofisher.com/au/en/home/brands/molecular‐probes/key‐molecular‐probes‐products/live‐dead‐viability‐brand‐page.html) utilizes green‐fluorescent Calcein‐AM and red‐fluorescent Ethidium Homodimer which indicate intracellular esterase activity in live cells and loss of plasma membrane integrity in dead cells respectively. Direct visualization of the cells by fluorescent imaging provides information approximately cell morphology and behavior within the hydrogel.77 Furthermore, spatial information regarding the position of live and dead cells within the bioscaffold can be obtained and this can inform at what extent the distance of cells from the light source affects cell survival.78 Meanwhile, quantitative information can be obtained by the counting of imaged cells. Alternatively to microscopic imaging, flow cytometry of single cells suspension from the bioscaffold can provide quantitative measurements.79 Table 2 highlights in the most recent literature the frequent use of LIVE/DEAD assay performed on bioscaffolds for cartilage repair to assess cytotoxicity.
Table 2.
Hydrogel | Photoinitiator (w/v) | Cross‐linking conditions | Cell type | Viability assay | Results | 3D bioscaffolds generation | References |
---|---|---|---|---|---|---|---|
PEGDA, HAMa, CSMa with RGD/RDG modifications | Irgacure 2959 (0.05% w/v) | UV light, 3.5 mW/cm2, 5 min | Primary bovine chondrocytes | LIVE/DEAD | All conditions supported cell viability. 86% of encapsulated cells were alive, and the presence of RGD did not enhance the chondrocyte viability | Casting of cells mixed with hydrogel in cylindrical molds | 80 |
GelMa (mGL) | LAP (0.15% w/v) | 430‐490 nm VL, 1400 mW/cm2, 4 min | hBMSCs |
LIVE/DEAD MTS assay |
92% viability after 90 days based on live/dead staining. MTS assay demonstrated significantly higher cell metabolic activity compared to non‐cross‐linked agarose constructs | Casting of cells mixed with hydrogel in silicon molds and then punched into 5 mm × 2 mm cylinder | 81 |
PEGDA | Irgacure 2959 (0.05% w/v) |
UV lamp (model B‐100AP; UVP) 4.5 mW/cm2 Photocrossinking was carried out simultaneously with printing (approx. 108 s) or for 10 min post‐printing |
Human articular chondrocytes | LIVE/DEAD | Cells viability with simultaneous photopolymerization was 89.2% ± 3.6%, compared with 63.2% ± 9.0% in post‐printing polymerization | HP Deskjet bioprinter in bovine osteochondral plugs | 82 |
GelMa‐HAMa | LAP (0.1%) | 365 nm, 700 mW/cm2, 10 s | hADSCs printed in a monoaxial configuration or separated from the PI using coaxial printing | LIVE/DEAD | The monoaxial group showed a viability decrease by 30% compared with coaxial printing at day 10 | Handheld bioprinting with Biopen device | 62 |
GelMa | Irgacure 2959 (0.5%) | 365 nm, 10, 100, and 700 mW/cm2 for 316, 100, and 37 s, respectively | hADSCs |
LIVE/DEAD CellTiter‐Blue cell viability assay |
At 100 mW/cm2 live/dead shows >90% viability. Metabolic tests show a significant decrease in the 700 mW light intensity group compared with the other groups | Casting of cells mixed with hydrogel in PDMS cylindrical molds | 50 |
Alg‐GelMa, Alg‐GelMa‐HAMa, Alg‐GelMa‐CSMa‐HAMa | Irgacure 2959 (0.05% w/w) | UV light, 6 mW/cm2, 30 s | hBMSCs | LIVE/DEAD | All groups showed >85% viability 3 hours after printing but it decreases over 3 wk. The Alg‐GelMa‐CSMa‐HAMa suffered the largest decline in viability | Custom coaxial dispensing system | 83 |
Gelatin furfurylamine | Rose Bengal (0.05% and 0.1%) | Vis light lamp, 2 min | Rabbit BMSCs | WST assay | Viability in 0.05% RB group was 87.3% at 24 hours, 55.8% on day 3% and 44.1% on day 7 after light exposure, whereas cells in the 0.1% RB group only showed 64% viability at 24 hours | Casting of cells mixed with hydrogel | 66 |
PLLA‐PEG 1000and PDLLA‐PEG 1000 | LAP (0.3%) | VL lamp 395 nm, 2 min | hBMSCs | LIVE/DEAD | Cell viability at day 7 was >85% in all groups | Cells pellet and hydrogels pipetted to fill multiple circular 5 mm diameter 2 mm height molds punched out of silicone rubber | 84 |
Methacrylated alginate at varying levels of methacrylation (8%–25%) | Irgacure 2959 (0.05% w/v) | 365 nm, 10 min | Primary bovine chondrocytes | LIVE/DEAD, MTS assay | Live/dead revealed >80% cell viability in all groups and MTS showed no significant differences | Casting of cells mixed with hydrogels in 24 well tissue culture plates | 85 |
Methacrylated alginate | Irgacure 2959 (0.5% w/v) or VA‐086 (0.5%) | 365 nm, 5 and 10 min | Primary bovine chondrocytes | LIVE/DEAD | Viability of the VA‐086 group remained over 90% at both time points and was similar to cells exposed to UV without the PI, whereas the Irgacure group fell to <20% after 5 min | Pouring of cells within hydrogel between two silanized glass plates spaced 1 mm apart | 63 |
Styrenated gelatin | Camphorquinone (0.1%w/w) | Visible light 400‐520 nm, 2 min, 800 mW/cm2 | Rabbit primary articular chondrocytes | MTT assay | Only 26% of viable cells were recovered from the hydrogel immediately after cross‐linking. This percentage decreases after 7 days | Cell–gelatin mixture casted in disk‐shaped gelatin hydrogel was approximately 2 mm in thickness, and that it contained 3 × 105 cells | 86 |
GelMa or PEGMA (BioINK) Hydrogel/PCL | Irgacure 2959 (0.05%) | UV light, 15 min | Porcine BMSCs | LIVE/DEAD | Analysis immediately after printing demonstrate >70% viability with no significant difference between groups | Casting in molds and bioprinting with 3D bioplotter RegenHU | 87 |
GelMa/Col |
Irgacure 2959 (0.05‐0.5 wt%) Ru/SPS (0.2/2 to 2/20 mM/mM) |
UV light, Vis light 3‐100 mW/cm2, 15 min |
hBM‐MSCs HACs |
LIVE/DEAD Alamar blue |
Even at low UV photoinitiator (I2959) concentrations (0.05 wt%), increasing UV irradiation dosage (30‐50 mW/cm2) causes a decrease in cell viability for both human articular chondrocytes and MSCs | BioScaffolder extrusion 3D bioprinting | 88 |
Abbreviations: Alg, alginate; CSMa, chondroitin sulfate methacrylate; GelMa, gelatin methacrylate; hADSC, human adipose‐derived stem cells; HAMa, hyaluronic acid methacrylate; hBMSC, human bone marrow‐derived stem cells; Irgacure 2959, 2‐hydroxy‐4′‐(2‐hydroxyethoxy)‐2‐methylpropiophenone; LAP, lithium phenyl‐2,4,6‐trimethylbenzoylphosphinate; MTS, tetrazolium reduction assay; MTT, 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide; PDLLA‐PEG 1000, poly‐d,l‐lactic acid/polyethylene glycol/poly‐d,l‐lactic acid; PEGDA, polyethylene glycol diacrylate; PLLA‐PEG 1000, poly‐l‐lactic acid/polyethylene glycol/poly‐l‐lactic acid; RDG, Arginine‐Aspartate‐Glycine; RGD, Arginine‐Glycine‐Aspartate; Rose Bengal, 4,5,6,7‐tetrachloro‐2′,4′,5′,7′‐tetraiodofluorescein; WST, 2‐(2‐methoxy‐4‐nitrophenyl)‐3‐(4‐nitrophenyl)‐5‐(2,4‐disulfophenyl)‐2H‐tetrazolium.
Other cell viability assays take advantage of cellular metabolic activity to estimate the number of viable cells in a sample. These include MTT (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide), WST (2‐(2‐methoxy‐4‐nitrophenyl)‐3‐(4‐nitrophenyl)‐5‐(2,4‐disulfophenyl)‐2H‐tetrazolium), and Resazurin reduction assays, the latter commonly made commercially available as CellTiter‐Blue Cell Viability Assay (eg, Promega Madison, WI 53711 USA, https://www.promega.com.au/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter_blue-cell-viability-assay/?catNum=G8080). Viable cells with active metabolism reduce the substrate to form a fluorescent product that can be detected and quantify by a plate reading spectrophotometer.89 Although this method is convenient owing to the ability of plate readers to analyze multiple wells at the same time, it does not enable the direct visualization of cells as by the LIVE/DEAD imaging. Despite its limited use in the literature, the combination of LIVE/DEAD kit with the metabolic assays could provide a more rigorous characterization of cellular viability (Table 2). Although there are many studies characterizing cell survival or the cytotoxic effects of UV light in bioscaffolds, there is limited evidence in the literature for the genotoxic effects such as the detection of double‐stranded DNA breaks or any of the lesions described above. The detection of the DNA integrity is necessary to assess the risk of tumorigenesis. However, although there are a multitude of techniques to analyze cells in a 2D monolayer, only one study has evaluated DNA damage in cells encapsulated within a 3D hydrogel scaffold. This study analyzed the genotoxic effects of photo‐crosslinking by utilizing P53‐binding protein 1 (p53BP1) as a marker of DNA damage.20 P53BP1 is a tumor suppressor which localizes to DSBs for DNA repair and can be detected and visualized through immunohistochemistry or western blot techniques.
Another marker of DNA damage, more specific for DSBs, is the phosphorylated form of the histone protein H2AX (pH2AX). pH2AX foci form in a 1:1 ratio with DSBs and are responsible for the recruitment of DNA repair proteins to the site of the lesion.90 Immunohistochemistry can be used to detect and quantify pH2Ax foci.91 Nevertheless, a protocol for the use of this technique in 3D bioscaffolds has not been established and its efficacy may be limited by poor antibody penetration through the cross‐linked hydrogel and background staining of the hydrogel. Alternate strategies which can be explored for the detection of these protein marker are western blotting of protein extracted from the 3D matrix and flow cytometry of single cells suspension from the scaffolds. Both this techniques are more specific than immunohistochemistry, overcome the complication of background staining, and allow quantification of the total amount of pH2AX in a cell population but foregoes 3D spatial information afforded by microscopy.92, 93
An alternative genotoxicity assay which could be adapted to analyze bioscaffolds is the comet assay, a microgel electrophoresis technique where cells with single and DSB migrate toward the anode in the shape of a comet.94 The degree of migration or length of the comet tail is proportional to the degree of DNA damage. This assay has been used across various cell types including mesenchymal stem cells. Although this technique has been used for analysis of cells in tissue engineered skin,95 it has not been used in photoencapsulated cells and would require a protocol to extract the cells from the scaffold without inflicting further DNA damage. As such, further investigation to develop a protocol for the detection of DSBs in cells within bioscaffolds is required.
6. STRATEGIES TO REDUCE CYTOTOXICITY
Both cytotoxicity and genotoxicity can be minimized by targeting the choice and the concentration of the PI or alternatively by the separation of cells from free radicals.
6.1. Photoinitiator choice and concentration
PI choice is typically based upon intrinsic properties such as their absorption spectra and its solubility limit in water. The efficiency of a PI at a wavelength of light is then determined by (a) its molar absorptivity at that wavelength, (b) the quantum yield of photolysis (the fraction of absorbed photons which produce free radicals), and (c) the PI efficiency (the ratio of initiation events to radicals generated). Unfortunately, a lack of such intrinsic data in the literature to date has severely hampered a rational comparison of relevant PIs.
The most commonly used PI in GelMa crosslinking is Irgacure 2959 which has been acclaimed for its water solubility and relatively low cytotoxicity.61 Irgacure 2959 has a peak absorption of 260 nm and although it can be activated at a higher wavelength of 365 nm, it has a cross‐linking time that is too long for clinical application as the extended period of UV exposure poses a risk of cytotoxicity.96
Across the literature, there are reports of PI concentrations ranging from 0.05% to 0.5% w/v with little consensus on the optimal concentration for cartilage tissue engineering.61, 97 Arguably, the optimal concentration will vary for the hydrogel being cross‐linked and the susceptibility of the cell type. Furthermore, Bartnikowski et al suggests that the number of reactive crosslinkable side chains on the monomers, termed degree of functionalization (DoF), should be accounted for in determining an optimal PI concentration.98 Chondrocytes encapsulated in “low DoF GelMA” displayed lower cell viability compared with “high DoF GelMA” following UV crosslinking with Irgacure 2959.
VA086, LAP, and Eosin Y are promising candidates. VA086 has a peak absorption of 370 nm but has been shown to crosslink hydrogels in an “ultrafast fashion” under illumination at 405 nm for only 10 seconds.61, 99 It has also been shown to be less cytotoxic than Irgacure 2959 to bovine articular chondrocytes following UV irradiation.63
More recently, LAP which has a peak absorbance of 385 nm but permits photo‐crosslinking at longer wavelengths, broaching the visible spectrum (405 nm), has gained popularity. It has higher water solubility compared with Irgacure 2959, thus permits cell encapsulation in PEGDA at lower PI concentrations and shorter light exposure times while maintaining >95% viability of human neonatal fibroblasts.49 In a comparison between UV (365 nm, 1560 mW/cm2, 5 seconds) and visible light (405 nm, 1650 mW/cm2, 5 seconds), irradiation of GelMa encapsulated odontoblast‐like cells with Irgacure 2959 and LAP, respectively, under the similar intensity, cell viability was significantly higher in cells exposed to the higher wavelength.100 Interestingly, a marked reduction was observed following 20 seconds of light exposure in the visible light/LAP samples which was not reflected in a UV/Irgacure group which exhibited superior viability for this crosslinking time. Nevertheless, the increased efficiency of LAP suggests that shorter light exposure times can yield sufficiently crosslinked hydrogels hence, the reduced viability observed at longer exposure times does not necessarily have a practical implication. Indeed, a short 10 second exposure time of LAP to UV light (365 nm, 700 mW/cm2) produces hardened GelMa‐HAMa scaffolds suitable for cartilage tissue regeneration whereas identical concentrations of other PIs such as Irgacure 2959 and VA‐086 did not achieve the same stiffness even after 2 minutes.5, 62
The use of visible light (>380 nm) with appropriate PIs can increase the safety of the photo‐crosslinking process by removing exposure to harmful mutagenic light wavelengths, thus maximizing cell viability and reducing the risk of malignant transformation. It has been shown that light at visible wavelength penetrate tissues at higher depths with lower energy compared with UV light, thus making it an efficient source for in situ photo‐crosslinking.101 Challenges to visible light crosslinking include the identification of a PI that is sensitive to visible wavelengths as well as identification of the optimal exposure time and power of the light source. Nevertheless, despite showing that the alternative PIs and light wavelength can reduce cell cytotoxicity, the introduction of mutations or DNA damage could not be excluded.
Eosin Y which has a peak absorbance of 530 nm and is being investigated as an injectable material has successfully crosslinked GelMa hydrogels under visible light.102, 103 Although its use in cell‐laden hydrogels is limited by intrinsic toxicity of the molecule itself, the use of coaxial printing methods which separate cells from the PI may warrant further investigation into the use of Eosin Y and other PIs in tissue engineering. In a recent study, Lim et al investigated the cytocompatibility of human chondrocytes laden GelMa hydrogels fabricated using a set of PIs which absorb in 400‐450 nm of the visible light range: ruthenium (Ru) and sodium persulfate (SPS).88, 104 The bioscaffolds have comparable physico‐mechanical properties as GelMA photo‐polymerized using Irgacure 2959 and LAP. Moreover, Ru/SPS system has a less adverse effect on the viability and metabolic activity of encapsulated cells for up to 35 days. The major advantages using the Ru/SPS system are significantly higher glycosaminoglycan content and redifferentiation capacity as compared with cells encapsulated using Irgacure 2959 and LAP, and significantly greater light penetration depth compared with the Irgacure 2959 system, allowing thick (10 mm) GelMA hydrogels to be fabricated with homogenous cross‐linking density throughout the construct.
Besides just photoinitiator concentration, light irradiation dose also significantly impacts cytotoxicity and the overall oxidative damage. In their paper, Lim et al showed that even at low PI (Irgacure 2959) concentrations (0.05 wt%), increasing UV irradiation dosage (30 to 50 mW/cm2) causes a decrease in cell viability for both human articular chondrocytes and MSCs.88
6.2. Coaxial extrusion
Given the detrimental effects of free radicals engendered by the photo‐crosslinking process, reducing cell exposure to the PI and its activation products is a possible solution to increase cell viability and protect the DNA molecule from genotoxic effects of free radicals. Coaxial extrusion allows the deposition of cells and the cross‐linking solution through separate internal and external needles, respectively.
This compartmentalization of cells within an inner, non‐crosslinked hydrogel “Core” surrounded by a photo‐crosslinked “Shell” is aimed at protecting vulnerable cells from the toxic effects intrinsic to the PI molecule and more importantly, from free radicals. The shielding effect of cells by the shell compartment increases the scope of materials that can be used for fabricating tissue constructs with a high cell viability. In cartilage tissue engineering, the coaxial method was found to be superior to the monoaxial configuration where cells are embedded throughout the hydrogel and exposed to the toxic photoinitiation process triggered by a fast high irradiance exposure to UV light. In Duchi et al, the cytotoxicity of bioprinted hADSCs upon 10 second irradiation with 365 nm at 700 mW/cm2 was found to be negligible, when cells were segregated from the PI, and the viability of UV only irradiated cells was comparable to the nonirradiated control group throughout 7 days.62 Moreover, high levels of cell survival immediately after printing and crosslinking with an increase in cell number 10 days following extrusion. In contrast monoaxial printed cells experienced a significant downturn in survival following photoinitiation and a further decrease over time.
7. CONCLUSIONS
The hydrogel material and the other additives required to harden the hydrogel itself constitutes the barriers to successful clinical translation of articular cartilage repair techniques using bioscaffolds. The photo‐crosslinking process is an efficient way to achieve a precise spatial and temporal hardening of the hydrogels, but, if not optimized, becomes a major source of cytotoxicity and genotoxicity within the process. These effects are mediated mostly by free radical photoproducts of PI activation, and to a lesser extent, UV light and intrinsic PI toxicity. Cytotoxic effects are regularly evaluated and reported in the literature, but the absence of potentially harmful, tumorigenic DNA lesions has not been proven. With the view of clinical application, safety of the implanted cells inside the bioscaffold is of utmost importance. Therefore, the routine use of standardized techniques to analyze cytotoxicity and genotoxicity, which can be utilized to test products and devices, should be mandatory. Meanwhile, continued investigation into methods of reducing cytotoxicity such as optimization of the photo‐crosslinking conditions or compartment segregation is necessary. Variables within the crosslinking process include PI type and concentration, light wavelength, intensity, and exposure time. Changes to these conditions alter the degree of crosslinking which are directly correlated with the mechanical stiffness of the hydrogel, but also affect cell viability and chondrogenic potential. Hence, both mechanical and biological properties must be considered in the identification of the optimal crosslinking condition. The final goal in the 3D bioscaffold‐based repair of articular cartilage is to deliver a product with enough stiffness to exist within the compressive articular space and support cell survival and chondrogenesis to regenerate healthy cartilage with minimal risk of tumorigenesis.
CONFLICT OF INTEREST
The authors indicated no potential conflicts of interest.
AUTHOR CONTRIBUTIONS
C.L., C.O., S.D.: conceived the literature review article, prepared the figures and the tables, and wrote the manuscript; C.D.O., C.D.B., P.F.M.C.: discussed and analytically revised the manuscript.
ACKNOWLEDGMENTS
This work was supported by Victorian Medical Research Acceleration Fund, Sylvia and Charles Viertel Charitable Foundation (VIERCI2018003), and St Vincent's Hospital (Melbourne) Research Endowment Fund. P.F.M.C. holds an NHMRC Practitioner Fellowship (APP1154203). Imaging assistance for graphical abstract was kindly provided by Maria Pia Cumani (DIBINEM Department University of Bologna, Rizzoli Orthopaedic Institute, Bologna, Italy).
Lee C, O'Connell CD, Onofrillo C, Choong PFM, Di Bella C, Duchi S. Human articular cartilage repair: Sources and detection of cytotoxicity and genotoxicity in photo‐crosslinkable hydrogel bioscaffolds. STEM CELLS Transl Med. 2020;9:302–315. 10.1002/sctm.19-0192
Funding information St Vincent's Hospital (Melbourne) Research Endowment Fund; Sylvia and Charles Viertel Charitable Foundation, Grant/Award Number: VIERCI2018003; Victorian Medical Research Acceleration Fund
DATA AVAILABILITY STATEMENT
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
REFERENCES
- 1. Guillemot F, Mironov V, Schneeberger K, et al. Biofabrication: reappraising the definition of an evolving field. Biofabrication. 2016;8:013001. [DOI] [PubMed] [Google Scholar]
- 2. Wu Y, Kennedy P, Bonazza N, et al. Three‐dimensional bioprinting of articular cartilage: a systematic review. Cartilage. 2018. 10.1177/1947603518809410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Martel‐Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072. [DOI] [PubMed] [Google Scholar]
- 4. Ye K, Di Bella C, Myers DE, et al. The osteochondral dilemma: review of current management and future trends. ANZ J Surg. 2014;84:211‐217. [DOI] [PubMed] [Google Scholar]
- 5. Onofrillo C, Duchi S, O'Connell CD, et al. Biofabrication of human articular cartilage: a path towards the development of a clinical treatment. Biofabrication. 2018;10:45006. [DOI] [PubMed] [Google Scholar]
- 6. Di Bella C, Duchi S, O'Connell CD, et al. In situ handheld three‐dimensional bioprinting for cartilage regeneration. J Tissue Eng Regen Med. 2018;12:611‐621. [DOI] [PubMed] [Google Scholar]
- 7. Graceffa V, Vinatier C, Guicheux J, Stoddart M, Alini M, Zeugolis DI. Chasing chimeras—the elusive stable chondrogenic phenotype. Biomaterials. 2019;192:199‐225. [DOI] [PubMed] [Google Scholar]
- 8. Francis SL, Di Bella C, Wallace GG, et al. Cartilage tissue engineering using stem cells and bioprinting technology—barriers to clinical translation. Front Surg. 2018;5:70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Levett PA, Melchels FP, Schrobback K, et al. Photocrosslinkable hydrogels for cartilage tissue engineering. J Tissue Eng Regen Med. 2012;6:68.21305699 [Google Scholar]
- 10. Hached F, Vinatier C, Le Visage C, et al. Biomaterial‐assisted cell therapy in osteoarthritis: from mesenchymal stem cells to cell encapsulation. Best Pract Res Clin Rheumatol. 2017;31:730‐745. [DOI] [PubMed] [Google Scholar]
- 11. Kean TJ, Lin P, Caplan AI, et al. MSCs: delivery routes and engraftment, cell‐targeting strategies, and immune modulation. Stem Cells Int. 2013;2013:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Klein TJ, Malda J, Sah RL, Hutmacher DW. Tissue engineering of articular cartilage with biomimetic zones. Tissue Eng Part B Rev. 2009;15:143‐157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Levato R, Webb WR, Otto IA, et al. The bio in the ink: cartilage regeneration with bioprintable hydrogels and articular cartilage‐derived progenitor cells. Acta Biomater. 2017;61:41‐53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Rehfeldt F, Engler AJ, Eckhardt A, et al. Cell responses to the mechanochemical microenvironment—implications for regenerative medicine and drug delivery. Adv Drug Deliv Rev. 2007;59:1329‐1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Yue K, Trujillo‐de Santiago G, Alvarez MM, Tamayol A, Annabi N, Khademhosseini A. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials. 2015;73:254‐271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Loessner D, Meinert C, Kaemmerer E, et al. Functionalization, preparation and use of cell‐laden gelatin methacryloyl‐based hydrogels as modular tissue culture platforms. Nat Protocols. 2016;11:727‐746. [DOI] [PubMed] [Google Scholar]
- 17. Daly AC, Freeman FE, Gonzalez‐Fernandez T, et al. 3D bioprinting for cartilage and osteochondral tissue engineering. Adv Healthc Mater. 2017;6:1‐20. [DOI] [PubMed] [Google Scholar]
- 18. Hu W, Wang Z, Xiao Y, Zhang S, Wang J. Advances in crosslinking strategies of biomedical hydrogels. Biomater Sci. 2019;7:843‐855. [DOI] [PubMed] [Google Scholar]
- 19. Singh S, Choudhury D, Yu F, et al. In situ bioprinting—bioprinting from benchside to bedside? Acta Biomater. 2019. [DOI] [PubMed] [Google Scholar]
- 20. Fedorovich NE, Oudshoorn MH, van Geemen D, Hennink WE, Alblas J, Dhert WJA. The effect of photopolymerization on stem cells embedded in hydrogels. Biomaterials. 2009;30:344‐353. [DOI] [PubMed] [Google Scholar]
- 21. Ning L, Betancourt N, Schreyer DJ, Chen X. Characterization of cell damage and proliferative ability during and after bioprinting. ACS Biomater Sci Eng. 2018;4:3906‐3918. [DOI] [PubMed] [Google Scholar]
- 22. Figueiredo L, Pace R, D'Arros C, et al. Assessing glucose and oxygen diffusion in hydrogels for the rational design of 3D stem cell scaffolds in regenerative medicine. J Tissue Eng Regen Med. 2018;12:1238‐1246. [DOI] [PubMed] [Google Scholar]
- 23. de Ruijter M, Ribeiro A, Dokter I, Castilho M, Malda J. Simultaneous micropatterning of fibrous meshes and bioinks for the fabrication of living tissue constructs. Adv Healthc Mater. 2019;8:1800418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Baugé C, Boumédiene K. Use of adult stem cells for cartilage tissue engineering: current status and future developments. Stem Cells Int. 2015;2015:438026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Rada T, Reis RL, Gomes ME. Adipose tissue‐derived stem cells and their application in bone and cartilage tissue engineering. Tissue Eng Part B Rev. 2009;15:113‐125. [DOI] [PubMed] [Google Scholar]
- 26. Veronesi F, Maglio M, Tschon M, Aldini NN, Fini M. Adipose‐derived mesenchymal stem cells for cartilage tissue engineering: state‐of‐the‐art in in vivo studies. J Biomed Mater Res A. 2014;102:2448‐2466. [DOI] [PubMed] [Google Scholar]
- 27. Hindle P, Khan N, Biant L, Péault B. The infrapatellar fat pad as a source of perivascular stem cells with increased chondrogenic potential for regenerative medicine. Stem Cells Translational Medicine. 2017;6:77‐87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Francis SL, Duchi S, Onofrillo C, et al. Adipose‐derived mesenchymal stem cells in the use of cartilage tissue engineering: the need for a rapid isolation procedure. Stem Cells Int. 2018;2018:9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Chen FH, Rousche KT, Tuan RS. Technology insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Rev Rheumatol. 2006;2:373‐382. [DOI] [PubMed] [Google Scholar]
- 30. Martin I, Ireland H, Baldomero H, Passweg J. The survey on cellular and engineered tissue therapies in Europe in 2012. Tissue Eng Part A. 2015;21:1‐13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Petkova R, Zhelev N, Pankov R, Chakarov S. Individual capacity for repair of DNA damage and potential uses of stem cell lines for clinical applications: a matter of (genomic) integrity. Biotechnol Biotechnol Equip. 2018;32:1352‐1358. [Google Scholar]
- 32. Galipeau J, Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22:824‐833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Krueger TEG, Thorek DLJ, Denmeade SR, Isaacs JT, Brennen WN. Concise review: mesenchymal stem cell‐based drug delivery: the good, the bad, the ugly, and the promise. Stem Cells Translational Medicine. 2018;7:651‐663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Duchi S, Sotgiu G, Lucarelli E, et al. Mesenchymal stem cells as delivery vehicle of porphyrin loaded nanoparticles: effective photoinduced in vitro killing of osteosarcoma. J Control Release. 2013;168:225‐237. [DOI] [PubMed] [Google Scholar]
- 35. Mumme M, Barbero A, Miot S, et al. Nasal chondrocyte‐based engineered autologous cartilage tissue for repair of articular cartilage defects: an observational first‐in‐human trial. Lancet. 2016;388:1985‐1994. [DOI] [PubMed] [Google Scholar]
- 36. Vega SL, Kwon MY, Burdick JA. Recent advances in hydrogels for cartilage tissue engineering. Eur Cell Mater. 2017;33:59‐75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Van den Steen PE, Dubois B, Nelissen I, et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase‐9 (MMP‐9). Crit Rev Biochem Mol Biol. 2002;37:375‐536. [DOI] [PubMed] [Google Scholar]
- 38. Schuurman W, Levett PA, Pot MW, et al. Gelatin‐methacrylamide hydrogels as potential biomaterials for fabrication of tissue‐engineered cartilage constructs. Macromol Biosci. 2013;13:551‐561. [DOI] [PubMed] [Google Scholar]
- 39. Caballero Aguilar LM, Kapsa RMI, O'Connell CD, et al. Controlled release from PCL‐alginate microspheres via secondary encapsulation using GelMa/HAMa hydrogel scaffolds. Soft Matter. 2019;15:3779‐3787. [DOI] [PubMed] [Google Scholar]
- 40. Chung C, Burdick JA. Influence of three‐dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. Tissue Eng Part A. 2009;15:243‐254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Levett PA, Hutmacher DW, Malda J, Klein TJ. Hyaluronic acid enhances the mechanical properties of tissue‐engineered cartilage constructs. PLoS One. 2014;9:e113216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Levett PA, Melchels FPW, Schrobback K, Hutmacher DW, Malda J, Klein TJ. A biomimetic extracellular matrix for cartilage tissue engineering centered on photocurable gelatin, hyaluronic acid and chondroitin sulfate. Acta Biomater. 2014;10:214‐223. [DOI] [PubMed] [Google Scholar]
- 43. Pereira RF, Bártolo PJ. 3D bioprinting of photocrosslinkable hydrogel constructs. J Appl Polym Sci. 2015;42458:1‐15. [Google Scholar]
- 44. Salinas CN, Anseth KS. The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials. 2008;29:2370‐2377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Salinas CN, Cole BB, Kasko AM, Anseth KS. Chondrogenic differentiation potential of human mesenchymal stem cells photoencapsulated within poly(ethylene glycol)‐arginine‐glycine‐aspartic acid‐serine thiol‐methacrylate mixed‐mode networks. Tissue Eng. 2007;13:1025‐1034. [DOI] [PubMed] [Google Scholar]
- 46. Holland TA, Tabata Y, Mikos AG. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release. 2005;101:111‐125. [DOI] [PubMed] [Google Scholar]
- 47. Teixeira LSM, Feijen J, van Blitterswijk CA, et al. Enzyme‐catalyzed crosslinkable hydrogels: emerging strategies for tissue engineering. Biomaterials. 2012;33:1281‐1290. [DOI] [PubMed] [Google Scholar]
- 48. Nguyen KT, West JL. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials. 2002;23:4307‐4314. [DOI] [PubMed] [Google Scholar]
- 49. Fairbanks BD, Schwartz MP, Bowman CN, Anseth KS. Photoinitiated polymerization of PEG‐diacrylate with lithium phenyl‐2,4,6‐trimethylbenzoylphosphinate: polymerization rate and cytocompatibility. Biomaterials. 2009;30:6702‐6707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. O'Connell CD, Zhang B, Onofrillo C, et al. Tailoring the mechanical properties of gelatin methacryloyl hydrogels through manipulation of the photocrosslinking conditions. Soft Matter. 2018;14:2142‐2151. [DOI] [PubMed] [Google Scholar]
- 51. Cadet J, Sage E, Douki T. Ultraviolet radiation‐mediated damage to cellular DNA. Mutat Res. 2005;571:3‐17. [DOI] [PubMed] [Google Scholar]
- 52. Brem R, Guven M, Karran P. Oxidatively‐generated damage to DNA and proteins mediated by photosensitized UVA. Free Radic Biol Med. 2017;107:101‐109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Beani JC. Ultraviolet A‐induced DNA damage: role in skin cancer. Bull Acad Natl Med. 2014;198:273‐295. [PubMed] [Google Scholar]
- 54. Aguiar PHN, Furtado C, Repolês BM, et al. Oxidative stress and DNA lesions: the role of 8‐oxoguanine lesions in trypanosoma cruzi cell viability. PLoS Negl Trop Dis. 2013;7:e2279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Andley UP, Lewis RM, Reddan JR, Kochevar IE. Action spectrum for cytotoxicity in the UVA‐ and UVB‐wavelength region in cultured lens epithelial cells. Invest Ophthalmol Vis Sci. 1994;35:367‐373. [PubMed] [Google Scholar]
- 56. Godar DE, Gurunathan C, Ilev I. 3D bioprinting with UVA1 radiation and photoinitiator irgacure 2959: can the ASTM standard L929 cells predict human stem cell cytotoxicity? Photochem Photobiol. 2019;95:581‐586. [DOI] [PubMed] [Google Scholar]
- 57. Wong DY, Ranganath T, Kasko AM. Low‐dose, long‐wave UV light does not affect gene expression of human mesenchymal stem cells. PLoS One. 2015;10:1‐21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Vilenchik MM, Knudson AG. Endogenous DNA double‐strand breaks: production, fidelity of repair, and induction of cancer. Proc Natl Acad Sci USA. 2003;100:12871‐12876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Lo H‐L, Nakajima S, Ma L, et al. Differential biologic effects of CPD and 6‐4PP UV‐induced DNA damage on the induction of apoptosis and cell‐cycle arrest. BMC Cancer. 2005;5:135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Cadet J, Douki T. Formation of UV‐induced DNA damage contributing to skin cancer development. Photochem Photobiol Sci. 2018;17:1816‐1841. [DOI] [PubMed] [Google Scholar]
- 61. Williams CG, Malik AN, Kim TK, Manson PN, Elisseeff JH. Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation. Biomaterials. 2005;26:1211‐1218. [DOI] [PubMed] [Google Scholar]
- 62. Duchi S, Onofrillo C, O'Connell CD, et al. Handheld co‐axial bioprinting: application to in situ surgical cartilage repair. Sci Rep. 2017;7:5837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Rouillard AD, Berglund CM, Lee JY, et al. Methods for photocrosslinking alginate hydrogel scaffolds with high cell viability. Tissue Eng Part C Methods. 2011;17:173‐179. [DOI] [PubMed] [Google Scholar]
- 64. Wessels M, Leyhausen G, Volk J, Geurtsen W. Oxidative stress is responsible for genotoxicity of camphorquinone in primary human gingival fibroblasts. Clin Oral Investig. 2014;18:1705‐1710. [DOI] [PubMed] [Google Scholar]
- 65. Bahney CS, Lujan TJ, Hsu CW, et al. Visible light photoinitiation of mesenchymal stem cell‐laden bioresponsive hydrogels. Eur Cell Mater. 2011;22:43‐55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Mazaki T, Shiozaki Y, Yamane K, et al. A novel, visible light‐induced, rapidly cross‐linkable gelatin scaffold for osteochondral tissue engineering. Sci Rep. 2014;4:4457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010;4:118‐126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Zhong H, Yin H. Role of lipid peroxidation derived 4‐hydroxynonenal (4‐HNE) in cancer: focusing on mitochondria. Redox Biol. 2015;4:193‐199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4‐hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11:81‐128. [DOI] [PubMed] [Google Scholar]
- 70. Dizdaroglu M, Jaruga P. Mechanisms of free radical‐induced damage to DNA. Free Radic Res. 2012;46:382‐419. [DOI] [PubMed] [Google Scholar]
- 71. Jiang D, Rusling JF. Oxidation chemistry of DNA and p53 tumor suppressor gene. ChemistryOpen. 2019;8:252‐265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Donigan KA, Sweasy JB. Sequence context‐specific mutagenesis and base excision repair. Mol Carcinog. 2009;48:362‐368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Albino AP, Huang X, Jorgensen ED, Gietl D, Traganos F, Darzynkiewicz Z. Induction of DNA double‐strand breaks in A549 and normal human pulmonary epithelial cells by cigarette smoke is mediated by free radicals. Int J Oncol. 2006;28:1491‐1505. [PubMed] [Google Scholar]
- 74. Cannan WJ, Pederson DS. Mechanisms and consequences of double‐strand DNA Break formation in chromatin. J Cell Physiol. 2016;231:3‐14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Sage E, Harrison L. Clustered DNA lesion repair in eukaryotes: relevance to mutagenesis and cell survival. Mutat Res. 2011;711:123‐133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Pfeiffer P, Goedecke W, Obe G. Mechanisms of DNA double‐strand break repair and their potential to induce chromosomal aberrations. Mutagenesis. 2000;15:289‐302. [DOI] [PubMed] [Google Scholar]
- 77. Gantenbein‐Ritter B, Potier E, Zeiter S, van der Werf M, Sprecher CM, Ito K. Accuracy of three techniques to determine cell viability in 3D tissues or scaffolds. Tissue Eng Part C Methods. 2008;14:353‐358. [DOI] [PubMed] [Google Scholar]
- 78. Gantenbein‐Ritter B, Sprecher CM, Chan S, Illien‐Jünger S, Grad S. Confocal imaging protocols for live/dead staining in three‐dimensional carriers In: Stoddart MJ, ed. Mammalian Cell Viability: Methods and Protocols. Totowa, NJ: Humana Press; 2011:127‐140. [DOI] [PubMed] [Google Scholar]
- 79. Johnson S, Nguyen V, Coder D. Assessment of cell viability. Curr Protoc Cytom. 2013;64:9.2.1‐9.2.26. [DOI] [PubMed] [Google Scholar]
- 80. Kim HD, Heo J, Hwang Y, et al. Extracellular‐matrix‐based and Arg‐Gly‐Asp‐modified photopolymerizing hydrogels for cartilage tissue engineering. Tissue Eng Part A. 2015;21:757‐766. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Lin H, Cheng AW, Alexander PG, et al. Cartilage tissue engineering application of injectable gelatin hydrogel with in situ visible‐light‐activated gelation capability in both air and aqueous solution. Tissue Eng Part A. 2014;20:2402‐2411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Cui X, Breitenkamp K, Finn MG, Lotz M, D'Lima DD. Direct human cartilage repair using three‐dimensional bioprinting technology. Tissue Eng Part A. 2012;18:1304‐1312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Costantini M, Idaszek J, Szoke K, et al. 3D bioprinting of BM‐MSCs‐loaded ECM biomimetic hydrogels for in vitro neocartilage formation. Biofabrication. 2016;8:35002. [DOI] [PubMed] [Google Scholar]
- 84. Sun AX, Lin H, Fritch MR, et al. Chondrogenesis of human bone marrow mesenchymal stem cells in 3‐dimensional, photocrosslinked hydrogel constructs: effect of cell seeding density and material stiffness. Acta Biomater. 2017;58:302‐311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Jeon O, Bouhadir KH, Mansour JM, Alsberg E. Photocrosslinked alginate hydrogels with tunable biodegradation rates and mechanical properties. Biomaterials. 2009;30:2724‐2734. [DOI] [PubMed] [Google Scholar]
- 86. Hoshikawa A, Nakayama Y, Matsuda T, Oda H, Nakamura K, Mabuchi K. Encapsulation of chondrocytes in photopolymerizable styrenated gelatin for cartilage tissue engineering. Tissue Eng. 2006;12:2333‐2341. [DOI] [PubMed] [Google Scholar]
- 87. Daly AC, Critchley SE, Rencsok EM, Kelly DJ. A comparison of different bioinks for 3D bioprinting of fibrocartilage and hyaline cartilage. Biofabrication. 2016;8:45002. [DOI] [PubMed] [Google Scholar]
- 88. Lim KS, Schon BS, Mekhileri NV, et al. New visible‐light photoinitiating system for improved print fidelity in gelatin‐based bioinks. ACS Biomater Sci Eng. 2016;2:1752‐1762. [DOI] [PubMed] [Google Scholar]
- 89. Prabst K, Engelhardt H, Ringgeler S, et al. Basic colorimetric proliferation assays: MTT, WST, and resazurin methods. Mol Biol. 2017;1601:1‐17. [DOI] [PubMed] [Google Scholar]
- 90. Kuo LJ, Yang LX. Gamma‐H2AX—a novel biomarker for DNA double‐strand breaks. In Vivo. 2008;22:305‐309. [PubMed] [Google Scholar]
- 91. Kim S, Jun DH, Kim HJ, Jeong KC, Lee CH. Development of a high‐content screening method for chemicals modulating DNA damage response. J Biomol Screen. 2011;16:259‐265. [DOI] [PubMed] [Google Scholar]
- 92. Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage In: Bjergbæk L, ed. DNA Repair Protocols. Totowa, NJ: Humana Press; 2012:613‐626. [DOI] [PubMed] [Google Scholar]
- 93. Redon CE, Nakamura AJ, Sordet O, et al. γ‐H2AX detection in peripheral blood lymphocytes, splenocytes, bone marrow, xenografts, and skin In: Didenko VV, ed. DNA Damage Detection In Situ, Ex Vivo, and In Vivo: Methods and Protocols. Totowa, NJ: Humana Press; 2011:249‐270. [DOI] [PubMed] [Google Scholar]
- 94. Speit G, Rothfuss A. The comet assay: a sensitive genotoxicity test for the detection of dna damage and repair In: Bjergbæk L, ed. DNA Repair Protocols. Totowa, NJ: Humana Press; 2012:79‐90. [DOI] [PubMed] [Google Scholar]
- 95. Flamand N, Marrot L, Belaidi J‐P, et al. Development of genotoxicity test procedures with Episkin®, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds? Mutat Res. 2006;606:39‐51. [DOI] [PubMed] [Google Scholar]
- 96. Tse JR, Engler AJ. Preparation of hydrogel substrates with tunable mechanical properties. Curr Protoc Cell Biol 2010;Chapter 10:Unit 10.16. [DOI] [PubMed]
- 97. Mironi‐Harpaz I, Wang DY, Venkatraman S, Seliktar D. Photopolymerization of cell‐encapsulating hydrogels: crosslinking efficiency versus cytotoxicity. Acta Biomater. 2012;8:1838‐1848. [DOI] [PubMed] [Google Scholar]
- 98. Bartnikowski M, Bartnikowski NJ, Woodruff MA, Schrobback K, Klein TJ. Protective effects of reactive functional groups on chondrocytes in photocrosslinkable hydrogel systems. Acta Biomater. 2015;27:66‐76. [DOI] [PubMed] [Google Scholar]
- 99. Wang Z, Jin X, Dai R, Holzman JF, Kim K. An ultrafast hydrogel photocrosslinking method for direct laser bioprinting. RSC Adv. 2016;6:21099‐21104. [Google Scholar]
- 100. Monteiro N, Thrivikraman G, Athirasala A, et al. Photopolymerization of cell‐laden gelatin methacryloyl hydrogels using a dental curing light for regenerative dentistry. Dent Mater. 2018;34:389‐399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Ullmann Y, Elkhatib R, Fodor L. The aesthetic applications of intense pulsed light using the lumenis M‐22 device. Laser Ther. 2011;20:23‐28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102. Noshadi I, Hong S, Sullivan KE, et al. In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels. Biomater Sci. 2017;5:2093‐2105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103. Lilly JL, Gottipati A, Cahall CF, Agoub M, Berron BJ. Comparison of eosin and fluorescein conjugates for the photoinitiation of cell‐compatible polymer coatings. PLoS One. 2018;13:e0190880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104. Lim KS, Klotz BJ, Lindberg GCJ, et al. Visible light cross‐linking of gelatin hydrogels offers an enhanced cell microenvironment with improved light penetration depth. Macromol Biosci. 2019;19:1900098. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing is not applicable to this article as no new data were created or analyzed in this study.